Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancers|July 29, 2023
<i>IDH</i> Mutations in Chondrosarcoma: Case Closed or Not?Sanne Venneker, Judith V M G Bovée
Virchows Archiv : an International Journal of Pathology|November 16, 2019
Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastomaSanne Venneker, Karoly Szuhai, Pancras C W Hogendoorn, et al.
Critical Reviews in Oncology/Hematology|June 20, 2025
Targeting the DNA damage response to enhance radiotherapy in soft tissue sarcomasBauke H G van Riet, Sanne Venneker, Judith V M G Bovée, et al.
Clinical Orthopaedics and Related Research|February 2, 2023
Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell ModelIeva Palubeckaitė, Sanne Venneker, Brendy E W M van den Akker, et al.
Frontiers in Molecular Biosciences|January 11, 2021
Selection of Effective Therapies Using Three-Dimensional <i>in vitro</i> Modeling of ChondrosarcomaIeva Palubeckaitė, Sanne Venneker, Inge H Briaire-de Bruijn, et al.
Cancers|December 8, 2019
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the <i>IDH1</i> or <i>IDH2</i> Mutation StatusSanne Venneker, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, et al.
Cancers|December 3, 2020
Beyond the Influence of <i>IDH</i> Mutations: Exploring Epigenetic Vulnerabilities in ChondrosarcomaSanne Venneker, Alwine B Kruisselbrink, Zuzanna Baranski, et al.
Clinical Sarcoma Research|June 5, 2019
Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genesYvonne de Jong, Martha Ingola, Inge H Briaire-de Bruijn, et al.
Nature Protocols|February 9, 2023
Quantitative multiple fragment monitoring with enhanced in-source fragmentation/annotation mass spectrometrySamuel Bernardo-Bermejo, Jingchuan Xue, Linh Hoang, et al.
Cancers|October 14, 2022
Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of BoneSanne Venneker, Robin van Eenige, Alwine B Kruisselbrink, et al.
Pageof 2